The global respiratory inhaler devices market is on the cusp of significant transformation over the next decade, driven by a rising incidence of respiratory diseases, technological advancements, and ...

The FDA is poised to issue a final decision on the approval and marketing of Yutrepia, an inhaled dry powder formulation of ...

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the U.S. Food and Drug ...

Italian biopharma Chiesi Group has announced a major investment in Nerviano, near Milan, with the building of a new facility ...

Italy's Chiesi Group has revealed plans to spend €430 million ($464 million) on a new therapeutics manufacturing facility at ...

A shuttered Milanese manufacturing site with a storied history is getting a new lease on life, thanks to a nearly ...

Despite the promising market growth, regulatory compliance and stringent guidelines continue to pose challenges for MDI ...

But that’s only the tip of what can cause dry hair—bleaching, overusing dry shampoo, heat styling, even the environment can leave strands dull and thirsty. And just like adding an eye cream ...

De Motu Cordis Pty Ltd (DMC) has been developing its simple, single-use inhaler, about the size of a pencil sharpener, that is designeddeliver adrenaline in a fine dry powder form. Pulling the red ...

These encompass soft mist inhalers, dry powder inhalers, pressurised metred-dose inhalers, nebulisers, nasal sprays and ophthalmic products for small and biologic molecules. It provides services in ...